Check out this interesting mini-bio of  Jim Higginbotham, the latest in IRMA’s “Meet a Friendly Rectal Microbicide Advocate” series on the IRMA website here.  Jim is one of five new bios posted last week. Jim HigginbothamBirmingham, Alabama, USA “I must continue to inspire others, especially the younger generation to carry the torch until the end of HIV.” Read More >>

Check out this interesting mini-bio of  Robert Bucklew, the latest in IRMA’s “Meet a Friendly Rectal Microbicide Advocate” series on the IRMA website here.  Robert is one of five new bios posted October 30, 2012. Robert BucklewCleveland, Ohio, USA Robert is the Outreach Coordinator for the Case Western Reserve University AIDS Clinical Trial Unit. He works on a Read More >>

via Science Speaks, by Antigone Barton When he looks at what biomedical science can do in the next decade to prevent HIV transmission, Jim Turpin of the National Institutes of Health said, he thinks of the lyrics of a Timbuk3 song: “The future’s so bright I gotta wear shades.” By, which, actually, he means — don’t get Read More >>

via The New England Journal of Medicine, by Joel M. Palefsky, M.D., Anna R. Giuliano, Ph.D., Stephen Goldstone, M.D., Edson D. Moreira, Jr., M.D., Carlos Aranda, M.D., Heiko Jessen, M.D., Richard Hillman, M.D., Daron Ferris, M.D., Francois Coutlee, M.D., Mark H. Stoler, M.D., J. Brooke Marshall, Ph.D., David Radley, M.S., Scott Vuocolo, Ph.D., Richard M. Haupt, M.D., Read More >>

via The New York Times, by Gardiner Harris Boys and young men should be vaccinated against human papillomavirus, or HPV, to protect against anal and throat cancers that can result from sexual activity, a federal advisory committee said Tuesday. The recommendation by the panel, the Advisory Committee on Immunization Practices of the Centers for Disease Control and Read More >>

via the Huffington Post, by Michael Warren “Now is exactly the time to maintain commitment. Now is exactly the time to hold a steady course in funding for basic science, clinical trials and product development. It’s good business sense: Our investments are paying off — and the dividend, in the form of an effective vaccine, would have Read More >>

via The Observer, by Shifa Mwesigye Excerpt: “Uganda has participated just like several other African countries; [in research] you must go where infection is happening. The majority of HIV research in the early stages happened in Uganda because Uganda was heavily infested with the virus. As you remember we had prevalence rates of above 20% and then Read More >>

via Medpage Today A vaccine against human papillomavirus (HPV) protects women against two strains of the virus that causes anal cancer, researchers reported. The vaccine (Cervarix) against HPV strains 16 and 18 offered “strong protection” against anal infection in a study whose main goal was to assess the efficacy of vaccination against cervical infection and pre-cancerous lesions, Read More >>

Via TIME, by Emily Rauhala. Last week, the Guardian broke the news that in the run-up to the raid on Osama bin Laden’s compound, the CIA used a vaccination campaign as a ruse to get DNA evidence from the al-Qaeda leader’s kids. With help from a Pakistani doctor, Shakil Afridi, they set up clinics in two neighborhoods, Read More >>

A report released yesterday by HIV Vaccines and Microbicides Resource Tracking Working Group at the IAS conference in Rome “found that overall investment in HIV prevention R&D had actually increased, with the modest exception of a one percent decline in vaccine R&D. The report documented a total US$1.19 billion investment in research and development (R&D) for four key HIV prevention Read More >>